• Je něco špatně v tomto záznamu ?

Effects of adenosine A1 receptor antagonism on insulin secretion from rat pancreatic islets

A. Zywert, K. Szkudelska, T. Szkudelski

. 2011 ; 60 (6) : 905-911.

Jazyk angličtina Země Česko

Perzistentní odkaz   https://www.medvik.cz/link/bmc12006338

Adenosine is known to influence different kinds of cells, including β-cells of the pancreas. However, the role of this nucleoside in the regulation of insulin secretion is not fully elucidated. In the present study, the effects of adenosine A1 receptor antagonism on insulin secretion from isolated rat pancreatic islets were tested using DPCPX, a selective adenosine A1 receptor antagonist. It was demonstrated that pancreatic islets stimulated with 6.7 and 16.7 mM glucose and exposed to DPCPX released significantly more insulin compared with islets incubated with glucose alone. The insulin-secretory response to glucose and low forskolin appeared to be substantially potentiated by DPCPX, but DPCPX was ineffective in the presence of glucose and high forskolin. Moreover, DPCPX failed to change insulin secretion stimulated by the combination of glucose and dibutyryl-cAMP, a non-hydrolysable cAMP analogue. Studies on pancreatic islets also revealed that the potentiating effect of DPCPX on glucose-induced insulin secretion was attenuated by H-89, a selective inhibitor of protein kinase A. It was also demonstrated that formazan formation, reflecting metabolic activity of cells, was enhanced in islets exposed to DPCPX. Moreover, DPCPX was found to increase islet cAMP content, whereas ATP was not significantly changed. These results indicate that adenosine A1 receptor blockade in rat pancreatic islets potentiates insulin secretion induced by both physiological and supraphysiological glucose concentrations. This effect is proposed to be due to increased metabolic activity of cells and increased cAMP content.

Citace poskytuje Crossref.org

Bibliografie atd.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc12006338
003      
CZ-PrNML
005      
20120906122746.0
007      
ta
008      
120229s2011 xr d f 000 0eng||
009      
AR
024    7_
$a 10.33549/physiolres.932165 $2 doi
040    __
$a ABA008 $d ABA008 $e AACR2 $b cze
041    0_
$a eng
044    __
$a xr
100    1_
$a Zywert, A. $u Department of Animal Physiology and Biochemistry, Poznan University of Life Sciences, Poznan, Poland
245    10
$a Effects of adenosine A1 receptor antagonism on insulin secretion from rat pancreatic islets / $c A. Zywert, K. Szkudelska, T. Szkudelski
504    __
$a Literatura $b 26
520    9_
$a Adenosine is known to influence different kinds of cells, including β-cells of the pancreas. However, the role of this nucleoside in the regulation of insulin secretion is not fully elucidated. In the present study, the effects of adenosine A1 receptor antagonism on insulin secretion from isolated rat pancreatic islets were tested using DPCPX, a selective adenosine A1 receptor antagonist. It was demonstrated that pancreatic islets stimulated with 6.7 and 16.7 mM glucose and exposed to DPCPX released significantly more insulin compared with islets incubated with glucose alone. The insulin-secretory response to glucose and low forskolin appeared to be substantially potentiated by DPCPX, but DPCPX was ineffective in the presence of glucose and high forskolin. Moreover, DPCPX failed to change insulin secretion stimulated by the combination of glucose and dibutyryl-cAMP, a non-hydrolysable cAMP analogue. Studies on pancreatic islets also revealed that the potentiating effect of DPCPX on glucose-induced insulin secretion was attenuated by H-89, a selective inhibitor of protein kinase A. It was also demonstrated that formazan formation, reflecting metabolic activity of cells, was enhanced in islets exposed to DPCPX. Moreover, DPCPX was found to increase islet cAMP content, whereas ATP was not significantly changed. These results indicate that adenosine A1 receptor blockade in rat pancreatic islets potentiates insulin secretion induced by both physiological and supraphysiological glucose concentrations. This effect is proposed to be due to increased metabolic activity of cells and increased cAMP content.
650    02
$a antagonisté adenosinového receptoru A1 $x farmakologie $7 D058916
650    02
$a adenosintrifosfát $x metabolismus $7 D000255
650    02
$a zvířata $7 D000818
650    02
$a AMP cyklický $x metabolismus $7 D000242
650    02
$a Dose-Response Relationship, Drug
650    02
$a inzulin $x sekrece $7 D007328
650    02
$a Langerhansovy ostrůvky $x metabolismus $x účinky léků $7 D007515
650    02
$a krysa rodu Rattus $7 D051381
650    02
$a potkani Wistar $7 D017208
650    02
$a receptor adenosinový A1 $x metabolismus $7 D043682
650    02
$a xanthiny $x farmakologie $7 D014970
700    1_
$a Szkudelska, K. $u Department of Animal Physiology and Biochemistry, Poznan University of Life Sciences, Poznan, Poland
700    1_
$a Szkudelsky, T. $u Department of Animal Physiology and Biochemistry, Poznan University of Life Sciences, Poznan, Poland
773    0_
$t Physiological research $x 0862-8408 $g Roč. 60, č. 6 (2011), s. 905-911 $w MED00003824
910    __
$a ABA008 $b A 4120 $c 266 $y 2
990    __
$a 20120229072848 $b ABA008
991    __
$a 20120906122917 $b ABA008
999    __
$a ok $b bmc $g 899391 $s 763166
BAS    __
$a 3
BMC    __
$a 2011 $b 60 $c 6 $d 905-911 $i 0862-8408 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
LZP    __
$a 2012-12/ipme

Najít záznam

Citační ukazatele

Nahrávání dat ...

    Možnosti archivace